Science ❯ Medical Research ❯ Clinical Trials

Phase 3 Trials

Vaccine Development Personalized Medicine LITESPARK-022 Trial TRUST-4 and SIGMA Trials Cancer Vaccines HERIZON-GEA-01 Trial ATOMIC Trial 536-Men VDPHL01 Trial I CAN Trial of Ultomiris in IgA Nephropathy

FDA Grants Accelerated Approval to Ultomiris for IgA Nephropathy

The decision allows use to reduce proteinuria while the I CAN trial finishes a long‑term kidney function analysis that will determine full approval.

FDA Approves Tecentriq With Chemotherapy for Stage III dMMR Colon Cancer

FDA Approves Zanidatamab Regimens for First‑Line HER2‑Positive Gastroesophageal Cancer